Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-13

Clinical Trial Update: The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating zonisamide with reinforcement to reduce alcohol use is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

Sponsor: Washington State University | Conditions: Alcohol Use Disorder (AUD) | Phase 2 | Status: RECRUITING